Skip to main content
Onco-Innovations logo

Onco-Innovations — Investor Relations & Filings

Ticker · ONCO ISIN · CA68237C1059 NEO Professional, scientific and technical activities
Open in API
Filings indexed 86 across all filing types
Latest filing 2025-09-19 Audit Report / Informat…
Country CA Canada
Listing NEO ONCO

About Onco-Innovations

https://oncoinnovations.com/

Onco-Innovations is a biotechnology company specializing in oncology research and the development of cutting-edge therapies to prevent and treat cancer. The company focuses on next-generation treatments, particularly those targeting solid tumors, leveraging an exclusive global license for patented technology. To advance precision oncology, Onco-Innovations utilizes the SynoGraph™ AI platform (acquired through Inka Health) to accelerate patient identification, optimize treatment planning, and streamline its drug development pipeline.

Recent filings

Filing Released Lang Actions
Statement of executive compensation (form 51-102F6V) - English.pdf
Audit Report / Information Classification · 1% confidence The document begins with “Independent Auditor’s Report” by McGovern Hurley, includes the auditor’s opinion, basis for opinion, key audit matters, responsibilities sections, followed by the fully consolidated financial statements (statements of financial position, loss, cash flows, changes in equity) for the years ended May 31, 2025 and 2024. It is a standalone audit report with audited financial statements, not an annual report narrative or earnings release. Therefore, it fits the definition of a standalone Audit Report / Information (AR). FY 2025
2025-09-19 English
News release - English.pdf
Board/Management Information Classification · 1% confidence The document is a news release announcing the appointment of Dr. John Mackey to the company’s Scientific & Clinical Advisory Board, which constitutes an announcement of a change in the company’s advisory/management body. This aligns with the Board/Management Information category (MANG).
2025-09-05 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate news release announcing the execution of a clinical start-up agreement and summarizing the collaboration with a CRO. It does not present financial results (not an ER or IR), is not a regulatory or audit report, and does not fit specialized categories (M&A, dividends, board changes, ESG, etc.). It is a general announcement without detailed investor presentation or proxy materials. As such, it falls into the fallback category for miscellaneous regulatory/press releases: Regulatory Filings (RNS).
2025-08-06 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate news release announcing a strategic partnership and service extension (marketing engagement) for Onco-Innovations and its subsidiary. It contains forward-looking statements, contact information, and background on the companies, but it is not a financial report, earnings release, board change notice, or similar. It is a general press announcement without detailed financial data or regulatory filings. It therefore best fits the fallback category of a general regulatory/press announcement (RNS).
2025-07-31 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV1 “Certification of Annual Filings” under Canadian NI 52-109, whereby the CEO certifies the annual financial statements, MD&A and AIF. It is not the annual report (10-K) itself nor an announcement of release; it is a regulatory compliance certificate. No more specific category matches, so it falls under General Regulatory Filings (RNS).
2025-07-30 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV1 Venture Issuer Basic Certificate signed by the CFO certifying the annual filings (AIF, MD&A, financial statements) for the year ended April 30, 2025. It is not the actual Annual Report or MD&A itself, nor an Earnings Release or other specific category. It is a regulatory compliance filing under Canadian NI 52-109, and does not fit any more specific category, so it defaults to the fallback Regulatory Filings classification (RNS).
2025-07-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.